Cyclosporin A blocks calcium-dependent pathways of gene activation.
We have used an interleukin-2 (IL-2) promoter-CAT fusion gene to study activation of IL-2 gene expression by IL-1, phytohemagglutinin (PHA), phorbol myristate acetate (PMA), and calcium ionophore in the murine thymoma line EL4 and the human lymphoma line Jurkat. The two cell lines respond differently to combinations of these stimuli. IL-1 in combination with suboptimal concentration of PMA induced chloramphenicol acetyltransferase (CAT) activity in EL4. In Jurkat cells, IL-1 failed to synergize with PMA or PHA. Cotransfection with the IL-2/CAT gene and a construct capable of expressing murine T-cell type IL-1 receptors converted Jurkat cells to IL-1 responsiveness. IL-1 in combination with PHA but not with PMA resulted in induction of CAT activity in these cells. Induction of IL-2/CAT activity by all stimuli in both cell lines was blocked by the presence of EGTA in the culture medium. EGTA did not inhibit IL-1/PMA activation of an SV40 early promoter-CAT fusion gene in either EL4 or Jurkat cells; therefore, calcium was not required for IL-1 or PMA signal transduction. Jurkat cells were shown to differ from EL4 in their requirement for calcium mobilization. Two different calcium-dependent pathways of gene activation were distinguished, both of which were blocked by the immunosuppressive drug cyclosporin A.
Baldari
C T
CT
Department of Evolutionary Biology, University of Siena, Italy.
Macchia
G
G
Heguy
A
A
Melli
M
M
Telford
J L
JL
D002118:Calcium / Q000502:physiology*; D016572:Cyclosporine / Q000494:pharmacology*; D004533:Egtazic Acid; D005786:Gene Expression Regulation; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D007376:Interleukin-2 / Q000235:genetics*; D010835:Phytohemagglutinins; D011401:Promoter Regions, Genetic; D011971:Receptors, Immunologic / Q000378:metabolism; D017472:Receptors, Interleukin-1; D015398:Signal Transduction; D013539:Simian virus 40 / Q000235:genetics; D013601:T-Lymphocytes / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured
D007375:Interleukin-1; D007376:Interleukin-2; D010835:Phytohemagglutinins; D011971:Receptors, Immunologic; D017472:Receptors, Interleukin-1; D004533:Egtazic Acid; D016572:Cyclosporine; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium